ESAIY
Price:
$8.34
Market Cap:
$1.45T
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2023-02-02
Stock Exchange
PNK
Ticker
ESAIY
According to Eisai Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.45T. This represents a change of -5.39% compared to the average of 1.53T of the last 4 quarters.
The mean historical Enterprise Value of Eisai Co., Ltd. over the last ten years is 1.01T. The current 1.45T Enterprise Value has changed 14.21% with respect to the historical average. Over the past ten years (40 quarters), ESAIY's Enterprise Value was at its highest in in the June 2023 quarter at 2.80T. The Enterprise Value was at its lowest in in the June 2024 quarter at 11.03B.
Average
1.01T
Median
878.94B
Minimum
16.26B
Maximum
2.16T
Discovering the peaks and valleys of Eisai Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.00%
Maximum Annual Enterprise Value = 2.16T
Minimum Annual Increase = -19.32%
Minimum Annual Enterprise Value = 16.26B
Year | Enterprise Value | Change |
---|---|---|
2024 | 1.74T | -19.32% |
2023 | 2.16T | -0.33% |
2022 | 2.16T | 9.93% |
2021 | 1.97T | 12.00% |
2020 | 16.26B | -1.10% |
2019 | 16.45B | -2.40% |
2018 | 16.85B | -6.36% |
The current Enterprise Value of Eisai Co., Ltd. (ESAIY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.02T
5-year avg
1.61T
10-year avg
1.01T
Eisai Co., Ltd.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eisai Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eisai Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Eisai Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Eisai Co., Ltd. (ESAIY)?
What is the 3-year average Enterprise Value for Eisai Co., Ltd. (ESAIY)?
What is the 5-year average Enterprise Value for Eisai Co., Ltd. (ESAIY)?
How does the current Enterprise Value for Eisai Co., Ltd. (ESAIY) compare to its historical average?